Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.51)
# 2,446
Out of 5,090 analysts
134
Total ratings
54.22%
Success rate
-1.29%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $23.92 | +25.42% | 5 | Nov 7, 2025 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $28 | $17.51 | +59.91% | 1 | Nov 7, 2025 | |
| DOCS Doximity | Maintains: Outperform | $81 → $70 | $51.31 | +36.43% | 10 | Nov 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $83 → $90 | $73.13 | +23.07% | 2 | Nov 5, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $190 → $220 | $199.19 | +10.45% | 10 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: In-Line | $9 → $8 | $7.78 | +2.83% | 6 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Outperform | $85 → $95 | $76.75 | +23.78% | 10 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $160 → $170 | $156.38 | +8.71% | 15 | Oct 30, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $17 → $13 | $11.27 | +15.40% | 8 | Oct 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $220 → $240 | $224.92 | +6.70% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $49.66 | +30.89% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $2.68 | +11.94% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $7 → $11 | $14.48 | -24.01% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $190 | $184.18 | +3.16% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $261.48 | +16.64% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $814.18 | +1.33% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $20.13 | +14.26% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.73 | +312.09% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $36 | $35.25 | +2.13% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $2.94 | +792.86% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $4.15 | +261.88% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $1.45 | +658.62% | 2 | Jan 4, 2022 |
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $23.92
Upside: +25.42%
Omada Health
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $17.51
Upside: +59.91%
Doximity
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $51.31
Upside: +36.43%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $83 → $90
Current: $73.13
Upside: +23.07%
Cardinal Health
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $199.19
Upside: +10.45%
Teladoc Health
Oct 30, 2025
Maintains: In-Line
Price Target: $9 → $8
Current: $7.78
Upside: +2.83%
CVS Health
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $76.75
Upside: +23.78%
Align Technology
Oct 30, 2025
Maintains: Outperform
Price Target: $160 → $170
Current: $156.38
Upside: +8.71%
DENTSPLY SIRONA
Oct 8, 2025
Maintains: In-Line
Price Target: $17 → $13
Current: $11.27
Upside: +15.40%
IQVIA Holdings
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $224.92
Upside: +6.70%
Oct 8, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $49.66
Upside: +30.89%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $2.68
Upside: +11.94%
Oct 8, 2025
Maintains: In-Line
Price Target: $7 → $11
Current: $14.48
Upside: -24.01%
Oct 8, 2025
Maintains: In-Line
Price Target: $185 → $190
Current: $184.18
Upside: +3.16%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $261.48
Upside: +16.64%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $814.18
Upside: +1.33%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $20.13
Upside: +14.26%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.73
Upside: +312.09%
Nov 7, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $35.25
Upside: +2.13%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $2.94
Upside: +792.86%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.15
Upside: +261.88%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.45
Upside: +658.62%